$COHU

Jones Jeffrey D sold $609K of COHU

Jones Jeffrey D (Sr. VP Finance & CFO) sold 13,000 shares of COHU INC (COHU) at $46.84 ($0.61M total) on 2026-05-22.

Original reporting
SEC EDGAR · Jones Jeffrey D
Published May 26, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$COHU
Neutral
medium confidence
Mentioned
$COHU
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COHUNeutralLow
01

Why it matters

The disclosure adds incremental information about insider behavior, but it does not include new guidance, financial results, contracts, or regulatory actions.

02

Market read

Traders may monitor insider activity as a sentiment input, but this specific Form 4 alone is unlikely to be a primary driver of COHU’s valuation.

03

What to watch

Insider sales should be weighed against prior Form 4 patterns, total insider holdings, and whether there is any concurrent company guidance or operational update, none of which is provided here.

Relevance 5/10Novelty 3/10Timing: filed 2026-05-26, transaction dated 2026-05-22

Background

The filing is a SEC Form 4 insider transaction for COHU, reported by CFO Jeffrey D. Jones.

Company-level read

Ticker impact

$COHUNeutralMedium confidence
Context

COHU disclosed a Form 4 showing CFO Jeffrey D. Jones sold 13,000 shares at $46.84 on 2026-05-22.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than earnings or guidance-driven.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size and price but no accompanying company-specific operational or financial change.

Market effects

Minimal; insider-sale disclosures rarely reset sector expectations without additional company news.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or tax-related, and the absence of a stated 10b5-1 plan does not necessarily imply negative information.

Key entities

  • COHU

    COHU Inc., the company whose insider transaction was reported.

  • Jeffrey D. Jones

    Sr. VP Finance & CFO who sold 13,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COHUHigh

Cohu Reports Third Quarter 2026 Results

COHU INC (COHU) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cohu Reports Third Quarter 2026 Results ● Third quarter net sales increased 37% year-over-year to $173.0 million ● Gross margin of 45.5%; non-GAAP gross margin of 45.7% ● Estimated test cell utilization increased 200 bps sequentially to 82% ● Bookings increased 126%

$COHUMed

Cohu beats third quarter estimates on strong AI demand

Cohu Inc. (COHU) reported Q3 earnings of $0.43 per share, beating estimates by $0.08, with revenue of $173.0M, up 37% YoY. Growth was driven by AI and high-performance computing demand. Shares rose 2% after hours. Q4 guidance is $171M-$185M, implying 46% YoY growth. GAAP net income was $12.1M, up from a loss last year.

$COHUMed

Cohu (COHU) Q2 2026 Earnings Call Transcript

Cohu’s Q2 2026 earnings call said sales rose 38% year over year to $149 million, with about 53% of revenue from recurring sources. The company cited higher semiconductor test utilization to 80% and said computing drove 46% of system orders. Cohu raised its fiscal 2026 high-performance computing revenue estimate to $100 million to $110 million.

$COHUMedAI 8/10

Cohu, Inc. Q2 2026 Earnings Call Summary

Cohu reported Q2 FY2026 revenue up 38% YoY, driven by advanced thermal test handlers for AI processors and HBM inspection. Semiconductor test utilization rose to 80%. The company raised its FY2026 revenue growth outlook to about 35% (range $610M-$615M) and expects Q3 revenue near $170M. Gross margin seen mid-40%.